tegafur has been researched along with Chronic Disease in 3 studies
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamashita, F | 1 |
| Tanaka, M | 1 |
| Fukumori, K | 1 |
| Ando, E | 1 |
| Yano, Y | 1 |
| Kato, O | 1 |
| Yamamoto, H | 1 |
| Fukuda, H | 1 |
| Kusaba, T | 1 |
| Tanikawa, K | 1 |
| Sata, M | 1 |
| Dovzhanskiĭ, SI | 1 |
| Suvorov, AP | 1 |
| Alekseenko, AV | 1 |
| Fedorak, SS | 1 |
| Seniutovich, RV | 1 |
| Iftodiĭ, AG | 1 |
| Vasilov, VI | 1 |
1 trial available for tegafur and Chronic Disease
| Article | Year |
|---|---|
A crossover study of oral administration of UFT in chronic liver disease: comparison of continuous and intermittent schedules.
Topics: Administration, Oral; Aged; Area Under Curve; Carcinoma, Hepatocellular; Chronic Disease; Cross-Over | 1998 |
2 other studies available for tegafur and Chronic Disease
| Article | Year |
|---|---|
[Use of fluorafur in the therapy of various chronic dermatoses].
Topics: Adult; Aged; Chronic Disease; Fluorouracil; Humans; Male; Middle Aged; Neurodermatitis; Psoriasis; S | 1977 |
[Treatment of pancreatitis by electrophoresis of cytostatics].
Topics: Acute Disease; Adult; Aged; Chronic Disease; Female; Fluorouracil; Humans; Iontophoresis; Male; Midd | 1988 |